MedPath

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

Phase 1
Completed
Conditions
Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi
Interventions
Registration Number
NCT05790902
Lead Sponsor
Armed Forces Institute of Urology, Rawalpindi
Brief Summary

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.

Detailed Description

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and quickly cures the disease thus enabling the person to return to routine activity with less adverse effects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • symptomatic, unilateral, single, uncomplicated Distal Ureteric Calculi of <10 mm in size (on plain CT KUB)
Exclusion Criteria
  • solitary kidney, bilateral ureteric stones, UTI, renal impairment, high-grade hydronephrosis (Grades 3 and 4), any history of previous endoscopic or surgical interventions, pregnancy, diabetes mellitus,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Silodosin GroupSilodosinThe patients used Silodosin for ureteric calculi
Tamsulosin GroupTamsulosinThe patients used Tamsulosin for ureteric calculi
Primary Outcome Measures
NameTimeMethod
Stone clearance rateupto 4 weeks

Stone clearance rate

Secondary Outcome Measures
NameTimeMethod
Stone expulsion timeupto 4 weeks

Stone expulsion time

Trial Locations

Locations (1)

AFIU Rawalpindi

🇵🇰

Rawalpindi, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath